Results 281 to 290 of about 5,469,182 (343)

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin   +11 more
wiley   +1 more source

Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study. [PDF]

open access: yesNutrients
Tosi M   +10 more
europepmc   +1 more source

Heat Preconditioning of Nanofat Does Not Improve Its Vascularization Properties. [PDF]

open access: yesCells
Bonomi F   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy